EXAS vs JAKK · rev $2.76B vs P/E 4.9, rev $245.9M
EXACT Sciences Corporation (EXAS) versus JAKKS Pacific Inc (JAKK) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
JAKKS Pacific Inc (JAKK) is a leisure company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported JAKK revenue for 2026-06-30 was $245.9M. Net income was $1.6M. JAKK currently screens at market cap $231.6M and trailing P/E 4.9.
EXAS currently screens at market cap $20.03B. JAKK currently screens at market cap $231.6M and trailing P/E 4.9.
Not investment advice. Open the EXAS and JAKK stock pages for the full models.
Not investment advice.